Genetic Determinants of Peanut‐Specific IgG4 Levels in the Context of Sustained Oral Peanut Exposure in the LEAP Study
Immunology · 2026-06 · 178 (2) · 280-292
DOI: 10.1111/imm.70098 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunology, online erschienen am 30.01.2026. Verfasst von Kanika Kanchan und 14 weiteren Autor:innen. Beteiligte Einrichtung: Genomics and Precision Health Section, Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of…. Hauptthemen laut MEDLINE: Peanut Hypersensitivity, Immunoglobulin G, Arachis, Allergens. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, NCATS NIH HHS, Intramural NIH HHS.
Abstract (Originalsprache)
In the Learning Early About Peanut Allergy (LEAP) study, participants in the peanut consumption group, at 60 months of age, had higher levels of peanut‐specific IgG4 (psIgG4), a biomarker of immune modulation, compared to those in the peanut‐avoidance group. We investigated the genetic determinants of psIgG4 among participants who consumed peanuts. Using whole‐genome sequencing data, we performed a genome‐wide association study (GWAS) for psIgG4 in the LEAP peanut consumption group participants ( N = 267). We generated a cumulative genetic score from the identified loci and evaluated its association with psIgG4 levels in LEAP. The association was then assessed for replication in two independent peanut oral immunotherapy (PnOIT) trials, IMPACT and POISED. We identified 45 variants that reached suggestive significance ( p < 1 × 10 −5 ), mapping to 17 independent loci in the LEAP peanut consumption group; none of these variants were associated with the psIgG4 levels in the avoidance group, highlighting a potential gene‐by‐environment (GxE) interaction. One locus on chromosome 2 showed regulatory signatures for SEPT2 , a gene involved in epithelial barrier function. The genetic score was significantly associated with psIgG4 among LEAP consumers ( β = 0.433; p = 1.20 × 10 −58 ) in the discovery cohort and IMPACT PnOIT participants ( β = 0.287; p = 0.02) in an independent testing cohort. No association was observed in older POISED PnOIT participants ( β = −0.029; p = 0.79). Identification of the SEPT2 locus in participants protected from peanut allergy (PA) suggests involvement of epithelial barrier pathways in modulating immune responses. Findings across all three trials emphasise the importance of GxE interactions, specifically the interplay between genetics and oral peanut exposure. Taken together, the findings indicate that early, sustained peanut consumption, combined with genetic factors, promotes a protective immune response to peanut allergens. Trial Registration: LEAP: NCT00329784; IMPACT: NCT03345160; POISED, NCT02103270
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Genomics and Precision Health Section, Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
- Benaroya Research Institute at Virginia Mason, Seattle, Washington, USA.
- The Department of Pediatric Allergy, Division of Asthma, Allergy and Lung Biology, King's College London, and Guy's and St. Thomas' NHS Foundation Trust, London, UK.
- Sean N. Parker Center for Allergy and Asthma Research, Stanford University, Palo Alto, California, USA.
- Institute of Genetic Medicine, Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
- The Immune Tolerance Network, San Francisco, California, USA.
ORCID-Profile: Kanika Kanchan, Monali Manohar, Kari C Nadeau, Stacie M Jones, Rasika A Mathias
Förderung
- NIAID NIH HHS
- NCATS NIH HHS
- Intramural NIH HHS
- National Center for Research Resources supported Clinical Translational Science Awards, and Clinical Research Centers
- TripAdvisor Charitable Foundation
- Immune Tolerance Network
- Food Allergy Research & Education Center of Excellence
- End Allergies Together
Zitieren
APA
Kanchan, K., Cerosaletti, K., Perry, J. A., DuToit, G., Manohar, M., Ling, H., Paschall, J. E., Sanda, S., Chinthrajah, R. S., Nepom, G. T., Nadeau, K. C., Jones, S. M., Lack, G., Ruczinski, I., & Mathias, R. A. (2026). Genetic Determinants of Peanut‐Specific IgG4 Levels in the Context of Sustained Oral Peanut Exposure in the LEAP Study. Immunology, 178(2), 280-292. https://doi.org/10.1111/imm.70098
Vancouver
Kanchan K, Cerosaletti K, Perry JA, DuToit G, Manohar M, Ling H, et al. Genetic Determinants of Peanut‐Specific IgG4 Levels in the Context of Sustained Oral Peanut Exposure in the LEAP Study. Immunology. 2026;178(2):280-292. doi:10.1111/imm.70098
BibTeX
@article{Kanchan2026,
author = {Kanchan, Kanika and Cerosaletti, Karen and Perry, James A and DuToit, George and Manohar, Monali and Ling, Hua and Paschall, Justin E and Sanda, Srinath and Chinthrajah, R Sharon and Nepom, Gerald T and Nadeau, Kari C and Jones, Stacie M and Lack, Gideon and Ruczinski, Ingo and Mathias, Rasika A},
title = {Genetic Determinants of Peanut‐Specific IgG4 Levels in the Context of Sustained Oral Peanut Exposure in the LEAP Study},
journal = {Immunology},
year = {2026},
volume = {178},
number = {2},
pages = {280--292},
doi = {10.1111/imm.70098}
}
EUVIMED